Back

Serological evidence of exposure to filoviruses in bats and humans in Ghana

Juman, M. M.; Riesle-Sbarbaro, S. A.; Amponsah-Mensah, K.; Gibson, L.; Mannerings, A.; Ntiamoa-Baidu, Y.; Fooks, A. R.; Ziekah, M.; Jephcott, F. L.; Languon, S.; Drummond, L.; Yan, L.; Broder, C. C.; Laing, E. D.; Drosten, C.; Suu-Ire, R. D.; Quaye, O.; Wood, J.; Cunningham, A. A.; Restif, O.

2026-07-02 public and global health
10.64898/2026.06.30.26356960 medRxiv
Show abstract

Filoviruses, including the likely bat-borne Ebola virus (EBOV) and Marburg virus (MARV), cause severe hemorrhagic fevers in humans. The 2013-2016 EBOV outbreak caused >11,000 human fatalities in Guinea, Liberia, and Sierra Leone. Nearby countries, including Ghana, have been under sampled for filoviruses relative to West African countries where large outbreaks have occurred. While there have been no reported EBOV disease cases in Ghana, there were two fatal MARV disease cases in 2022, suggesting that at least one filovirus is circulating in the country. In this study, we investigated filovirus circulation in fruit bats and humans in Ghana. We leveraged an extensive serological dataset collected from multiple fruit bat species (n = 6,874) and humans (n = 1,300) across a decade in Ghana (2010-2020), including both rural and urban regions. We observed evidence of MARV circulation in Rousettus aegyptiacus bats, a presumed reservoir, as well as occasional seropositivity in sympatric bat species, suggesting that these other bats are incidental, dead-end hosts. Multivariate analyses suggested that multiple, partially cross-reactive filoviruses are circulating among fruit bats in Ghana. Finally, people who reported spending time in caves and hunting bats had higher serological reactivity against EBOV and MARV relative to individuals with no direct bat exposure, indicating possible undetected filovirus spillover at the bat-human interface in Ghana.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
The Journal of Infectious Diseases
202 papers in training set
Top 0.1%
14.7%
2
PLOS Neglected Tropical Diseases
466 papers in training set
Top 1%
7.8%
3
PLOS ONE
5266 papers in training set
Top 23%
7.2%
4
The American Journal of Tropical Medicine and Hygiene
68 papers in training set
Top 0.2%
6.2%
5
PLOS Global Public Health
344 papers in training set
Top 3%
5.1%
6
Emerging Infectious Diseases
105 papers in training set
Top 0.2%
4.8%
7
International Journal of Infectious Diseases
129 papers in training set
Top 0.5%
4.0%
8
Scientific Reports
3612 papers in training set
Top 30%
3.4%
50% of probability mass above
9
Nature Communications
5641 papers in training set
Top 34%
3.4%
10
BMC Infectious Diseases
133 papers in training set
Top 1%
3.2%
11
BMC Medicine
176 papers in training set
Top 2%
2.1%
12
Journal of Virology
499 papers in training set
Top 2%
1.7%
13
BMJ Open
601 papers in training set
Top 9%
1.7%
14
Epidemics
116 papers in training set
Top 1%
1.7%
15
PLOS Pathogens
820 papers in training set
Top 6%
1.7%
16
BMJ Global Health
113 papers in training set
Top 2%
1.5%
17
One Health
29 papers in training set
Top 0.3%
1.5%
18
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.3%
19
eLife
5828 papers in training set
Top 58%
1.1%
20
Virus Evolution
155 papers in training set
Top 1%
1.1%
21
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.1%
22
Virology Journal
32 papers in training set
Top 0.6%
1.1%
23
Epidemiology and Infection
89 papers in training set
Top 2%
1.1%
24
COVID
14 papers in training set
Top 0.5%
0.8%
25
Wellcome Open Research
67 papers in training set
Top 2%
0.8%
26
Microbiology Spectrum
469 papers in training set
Top 10%
0.8%
27
Viruses
332 papers in training set
Top 5%
0.8%
28
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.4%
0.8%
29
The Lancet Infectious Diseases
73 papers in training set
Top 1%
0.8%
30
Transboundary and Emerging Diseases
37 papers in training set
Top 0.6%
0.8%